Ligand validation:8FGJ

XVZ: 6-{2-[5-(2-aminoethyl)-2,3-difluorophenyl]ethyl}-4-methylpyridin-2-amine

XVZ is a Ligand Of Interest in 8FGJ designated by the Author

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
8FGJ_XVZ_B_803	50%	27%	0.194	0.946	0.42	2.61	-	9	0	0	100%	1
8FGJ_XVZ_C_803	47%	30%	0.179	0.921	0.39	2.47	-	9	1	0	100%	1
8FGJ_XVZ_D_804	35%	34%	0.218	0.908	0.42	2.27	-	9	0	0	100%	1
8FGJ_XVZ_A_803	26%	27%	0.249	0.891	0.53	2.51	-	10	0	0	100%	1
8FGJ_XVZ_B_804	15%	48%	0.219	0.776	0.39	1.62	-	6	0	0	100%	1
8FGJ_XVZ_C_804	15%	47%	0.259	0.816	0.49	1.55	-	5	1	0	100%	1
8FGC_XVZ_B_803	24%	36%	0.292	0.923	0.51	2.09	-	9	1	0	100%	1
8FGR_XVZ_B_501	66%	45%	0.149	0.956	0.55	1.6	-	5	2	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM133198.